Close Menu

Ebola

Photo of Nathan Ledeboer

Point-of-care testing, automation, and panelization of nucleic acid amplification testing are the future of the clinical lab ― and will likely change how labs and clinicians relate.

The method may be deployed as part of the Broad's collaboration with Illumina and USAID to study Ebola in some West African countries hit by the outbreak.

The Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation awarded the grant to Cepheid to develop the test.

NEW YORK (GenomeWeb) – Tekmira Pharmaceuticals may not be able to meet its year-end goal of providing US regulators with the data required to lift a hold on a Phase I trial of its investigational Ebola therapy TKM-Ebola, company officials disclosed last week.

NEW YORK (GenomeWeb) – Host genetics appear to play a role in response to Ebola virus infection, researchers reported in a paper appearing online in Science today.

NEW YORK (GenomeWeb) — With a new technique to embed and freeze-dry genetic networks in paper, researchers from the Wyss Institute at Harvard University have taken the first steps toward moving a range of molecular diagnostics that currently rely on more complex technologies into a just-add-water

NEW YORK (GenomeWeb) – BioFire Defense, a BioMérieux company, has been granted Emergency Use Authorization by the US Food and Drug Administration for BioThreat-E, a commercially available Ebola molecular diagnostic test for use in CLIA moderate- and high-complexity laboratories.

NEW YORK (GenomeWeb) — BioMérieux yesterday reported approximately 4 percent organic revenue growth for the first nine months of 2014, driven by organic growth in all of its clinical application areas but particularly in molecular biology and immunoassays.

NEW YORK (GenomeWeb) – Using fever to screen for Ebola casts a wide net, while standard RT-PCR requires many hours and expert technicians.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.